BUD vs CPHI
BUD (BUD) versus China Pharma Holdings Inc (CPHI) — a side-by-side from cached financials, not a winner call.
BUD (BUD) common stock.
China Pharma Holdings Inc (CPHI) is a drug manufacturers - specialty & generic company listed on US.
BUD does not have a complete income-statement cache yet.
Latest reported CPHI revenue for 2025-12-31 was $4.1M. Net income was -$3.2M. Revenue was down 8.5% from 2024-12-31 to 2025-12-31. CPHI currently screens at market cap $29.0M.
BUD currently screens at market cap $0. CPHI currently screens at market cap $29.0M.
Not investment advice. Open the BUD and CPHI stock pages for the full models.
Not investment advice.